chrisvoncsefalvay/vaers-outcomes huggingface dataset:
12 month vaccines given yesterday, 10/9/08.  Mom called the morning of 10/10/08 reporting itchy welts to bilateral legs.  Exam revealed an arthus reaction with no known exposure to insect bites.  She had 4 oval, raised erythematous lesions of 1cm x 1 cm on left outer leg, and two larger areas on right leg of 2x2 cm and 2x0.5cm with slight central clearing.  Will treat with Locoid steroid cream and Benadryl 1/2 tsp every 6 hours as needed.
Patient became hot diaphoretic, and nauseated after the shot. Patient states has some anxiety. Blood pressure  98/60,80, patient states he felt better after calming down  blood pressure 116/62,Patient refused to go to hospital. Patient signed refusal and left with his mom
2 Hours after vaccinated I felt hot  from my neck to my head, with slight headache. went away after 3H.  Had chills, slight fever and Body aches that night. Took Advil 400mg, felt better. The following day the site of injection was sore,  felt warm,  temperature was 99.9 degrees F,  had chills and sneezing, like my seasonal allergies,  with body aches. Took Advil 400mg and Zyrtec. Felt better. Today I had body aches and soreness @ the site of injection. Took Advil 400mg, now I am feeling better.
After receiving my 2nd dose of Pfizer in July 2021 I experienced severed swelling and pain at the injection site. I was very tired and experienced muscle fatigue. On 1/27/22 I received my booster and experienced the same symptoms except this time I was unable to move my left arm. I also experienced itching, swelling, redness and pain at the injection site. I again experienced tiredness, muscle fatigue and was extremely lethargic.
Redness, heat, pain and swelling at injection site, spreading over a 48 hour period. 1st noted at 1300 4/2/21,  24 hrs post injection 2 (019B21A). Doubled in size over the next 24 hours. No systemic fever. Developed a systemic rash during the night of 4/2/21. No signs or symptoms of anaphylaxis. Takes 80 mg Pepcid BID and Extra Strength Tylenol BID, added 25 mg Benadryl QID
administered only the liquid component of the Arexvy vaccine and not the powder; administered only the liquid component; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a 80-year-old female patient who received RSVPreF3 adjuvanted (Arexvy) (batch number 2B775, expiry date 13-DEC-2024) for prophylaxis.   On 23-AUG-2023, the patient received Arexvy. On 23-AUG-2023, an unknown time after receiving Arexvy, the patient experienced inappropriate preparation of medication (Verbatim: administered only the liquid component of the Arexvy vaccine and not the powder) and inappropriate dose of vaccine administered (Verbatim: administered only the liquid component).  The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK Receipt date: 28-AUG-2023 A pharmacist reported that a patient was administered only the liquid component of the Arexvy vaccine and not the powder, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. Healthcare professional planning on revaccinating the patient.  The reporter consented to follow up.
vaccine was kept in refrigerator on 4Jun2022 and administered on 22Jul2022; No adverse event; Dose administered after 30-day Use By Date or after manufacturer date of expiry; This spontaneous case was reported by a physician assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date or after manufacturer date of expiry), PRODUCT STORAGE ERROR (vaccine was kept in refrigerator on 4Jun2022 and administered on 22Jul2022) and NO ADVERSE EVENT (No adverse event) in a 66-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058A22-2A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 22-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 22-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date or after manufacturer date of expiry). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (vaccine was kept in refrigerator on 4Jun2022 and administered on 22Jul2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date or after manufacturer date of expiry), PRODUCT STORAGE ERROR (vaccine was kept in refrigerator on 4Jun2022 and administered on 22Jul2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date or after manufacturer date of expiry) and PRODUCT STORAGE ERROR (vaccine was kept in refrigerator on 4Jun2022 and administered on 22Jul2022).    No concomitant drug information was provided.  Patient had received half dose of the vaccine.  Vial was initially stored in refrigerator on 04-Jun-2022. The product hadn't undergone any temperature excursion issue.  No treatment drug information was provided.
Doses administered past the 30-day use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Doses administered past the 30-day use by date) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination.     No Medical History information was reported.    In February 2022, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Doses administered past the 30-day use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Doses administered past the 30-day use by date) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported.  Reporter called to report they gave 26 doses after the 30-day use by date. It was reported that the vial was initially stored in the refrigerator on 14 Jan 2022. The dates of vaccine administration were 14 Feb 2022, 15 Feb 2022, 16 Feb 2022, 18 Feb 2022, 21 Feb 2022.  No treatment medication was reported.
This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not provided. On 01-APR-2016, the patient was vaccinated with an improperly stored dose of rotavirus vaccine (manufacturer unknown) reported lot# L026553, expiration date: 16-JUL-2017 (route and site of administration were not reported). Concomitant therapies were not provided. According to the reporter, the vaccine was stored at temperature of 11.1 Celsius degree for 1 hour and 36 minutes and also at a temperature of -12.3 Celsius degree for 1 hour and 33 minutes (excursion dates were not reported). No adverse symptoms were reported. No product quality complain (PQC) was involved. This is one of several reports received from the same reporter. Additional information has been requested.
w/in a few seconds p/vax pt exp tonic-clonic movements of hands & face; eyes rolled back; lost consciousness; no drooling; no h/o sz disorder; temp 98.3, BP nl; dx vaso-vagal reaction; EEG abn w/slowing for age;
Coughing up phelm; Occasional running of the nose; Little horseness in her voice; This is a spontaneous report from a contactable consumer (patient) or other non-health care professional via medical information team. A 64-year-old female patient received bnt162b2 (Pfizer-BioNTech Covid-19 Vaccine, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on 06May2021 as dose 1, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. Patient received her first Pfizer Covid 19 Vaccine on Thursday 06May2021. She is scheduled to receive the second Pfizer Covid 19 Vaccine on 27May2021. On 09May2021 she reports coughing up phelm with occasional running of the nose. Patient has been outside some with head wet not covered up. She has noticed a little horseness in her voice along with coughing. Description of COVID-19 Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the novel coronavirus, SARS-CoV-2, that appeared in late 2019. It is predominantly a respiratory illness that can affect other organs. People with COVID-19 have reported a wide range of symptoms, ranging from mild symptoms to severe illness. Symptoms may appear 2 to 14 days after exposure to the virus. Symptoms may include fever or chills; cough; shortness of breath; fatigue; muscle or body aches, headache; new loss of taste or smell; sore throat; congestion or runny nose; nausea or vomiting; diarrhea. The clinical outcome of the event was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
No adverse event; the medical assistant made a miistake and gave it to the wrong patient; Indicate in which point in the process the medication error ocurred: dispending; Medical assistant calls tor report VAQTA dose given twice in 2 weeks. 2nd dose given today; This spontaneous report was received from a physician concerning to a 12-month-old female patient with otitis media. The patient{s medical history was not provided and her concomitant medications included ceftriaxone sodium (ROCEPHIN).  On 19-JUN-2023, the patient was vaccinated with the first dose of hepatitis a vaccine, inactivated(VAQTA) for prophylaxis (strength, dose, route, frequency, lot# and expiration date were not provided). On 26-JUN-2023, due a dispensing issue, the patient was accidentally vaccinated with a second dose of hepatitis a vaccine, inactivated (VAQTA) (inappropriate schedule of product administration) which was supposed to be given to another patient (wrong patient received product). No adverse effect were reported.
On 7/25/16 received TRUMENBA vaccine, 24 hours later developed vomiting, weakness, HA, sweats, generalized malaise and joint pain.
patient got VZV/Tdap/MCV 4, and was sitting on bench for about 5 minutes for observation.  on getting up, he experienced syncopal episode, hit the back of his head (occiput) with several seconds of loss of consciousness.  after 10 minutes, he complained of headache,nausea, confusion, and vomited 1 time.
On 3/14/01 the pt experienced chest pain, sharp pain on the right side. Respiration did not intensify. The pt experienced intermittent episodes since then.
No adverse effects reported; Patient received improperly stored PROQUAD; This spontaneous report was received from registered nurse and refers to an approximately 4-year-old patient (reported as most likely around 4 years) of unknown gender. The patient's concurrent conditions and medical history were not reported. On 28-MAY-2019, the patient was vaccinated with improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) from lot # R026351 with expiry date 15-MAR-2020 for prophylaxis (dose, route, and anatomical location were not reported) (product storage error). Concomitant therapy included properly stored sterile diluent (lot # S000130, expiry date: 23-AUG-2021). The vaccine was exposed to a temperature excursion of 6 degree Fahrenheit (F) to 14 F (6.4 F) for 1 hour and 30 minutes. There was no previous temperature excursion. Digital data logger was involved. No adverse effects were reported. No product quality compliant (PQC) was reported.  This is one of the three reports received from the same reporter.
Left upper arm is pinkish-red/swollen from shoulder to elbow. Normal range of motion. Neuro-vascular intact. TX: Benadryl 3/4 5 po q 8 hrs X 3 days. Ice pack prn; Motrin 1 1/2 t po q 8hrs X 3 days. Follow-up not complete.
Patient developed a raised rash all over the body approximately 1.5 days after being vaccinated. Mother treated with Benadryl and a topical cream. The rash would disappear and reappear about every 4 hours when the Benadryl wore off. The rash lasted for about 5 days.
SORE THROAT; HOARSE VOICE; CHILLS; FEVER; HEADACHE; ACHES; This spontaneous report received from a patient concerned a 29 year old male. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805031, and batch number: 1805031 expiry: UNKNOWN) dose was not reported, administered on 20-MAR-2021 to right arm for prophylactic vaccination. No concomitant medications were reported. On 20-MAR-2021, the subject experienced aches. On 20-MAR-2021, the subject experienced chills. On 20-MAR-2021, the subject experienced fever. On 20-MAR-2021, the subject experienced headache. Laboratory data included: Body temperature (NR: not provided) 100 F. On 30-MAR-2021, the subject experienced sore throat. On 30-MAR-2021, the subject experienced hoarse voice. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from aches, chills, fever, and headache on 21-MAR-2021, and had not recovered from sore throat, and hoarse voice. This report was non-serious.
Her shoulder was sore for several days - Doctor said flu shot was given too high in the arm.
Initial report received from an health care professional on 29 Jul: This patient was vaccinated with only the 0.5 ml of the MenCYW-135 component of MENVEO (batch number: (box lot: 10003 and liquid vial lot: 091001), without the lyophilized Men A conjugate compound, No adverse events had occurred following this administration.
COVID rebound; COVID rebound; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 50-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 10Mar2021 as dose 1, single (Batch/Lot number: unknown), in left arm and on 31Mar2021 as dose 2, single (Batch/Lot number: unknown) at the age of 48 years, in left arm for covid-19 immunisation. The patient was not pregnant at the time of vaccination. The patient's relevant medical history included: "Asthma" (unspecified if ongoing). No known allergies. There were no concomitant medications.  The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID rebound". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results. Therapeutic measures were taken as a result of Drug ineffective, covid-19. Patient received COVID 19 treatment with Paxlovid from 23Jun2022 to 28Jun2022. Patient experienced Covid rebound from 02Jul2022 to 09Jul2022 (Recovered) and no treatment.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
At the time of vaccination, I had a headache and sore arm and felt tired for 24 hrs or so.      My last check in report I would like to change my health status to serious vertigo experience beginning on May 1, 2021.  In the middle of the night while in bed I felt like I was falling.  The next day I had the need to fall to the left side all the way to the floor 2 times safety and felt very dizzy for the 2 days.  I began my balance exercises.  I continue to have frequent serious dizziness episodes since May 1.  Can this recent on set of strong vertigo be a result of the vaccine?  Until now all vertigo expressions were mild.
Information has been received from a physician assistant concerning a female (age not reported) who was vaccinated (date, route and site not reported) with the 2nd dose of GARDASIL (lot# not reported). The patient experienced a "severe reaction at the site of injection" after receiving the 2nd dose of GARDASIL. The patient developed swelling, discomfort and redness at injection site which lasted for 2 weeks. The patient received medical attention via the telephone and recovered on an unspecified date. No further information is available.
Pt waited in store about an hour after shot given, said experienced weakness, dizziness, and numbness in left arm; was feeling better at about an hour post shot. Stated has poor circulation normally in extremities and this could be due to hunger. Also felt foggy.
Approximately 10 minutes after administration, patient fainted. He woke up within 30 seconds, blood pressure 110/80; HR = 70.
Sudden onset of vomiting at 23:00 X 3 within 1 hour. Taken to ER with a 2 hour wait, vomited X 2. Phenergan suppository administered and returned home. Awoke in the morning of 2/29/2000, no discomfort or distress. No other symptoms.
No adverse affects reported; a patient was administered there first dose of MMR II at 23 months of age on 5/28/2018 and the second dose was administered on 6/28/2019; This spontaneous report has been received from a nurse referring to a 36 months patient of unknown gender. Information regarding the patient's pertinent medical history, concurrent conditions, concomitant medications and drug reactions/allergies was unknown.  On 28-MAY-2018, the patient was vaccinated with first dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) at 23 months, and the second dose was vaccinated on 28-JUN-2019 for prophylaxis (strength, dose, route, lot # and expiration date of both doses were not reported) (inappropriate schedule of vaccine administered).   The patient didn't experience adverse event (no adverse event). No additional information was provided.
Post menopausal for 8 years. Onset of mild low abdominal pain and vaginal bleeding. Under investigation by Dr. Had pelvic ultrasound with vaginal probe. Scheduled for uterine biopsy.
This spontaneous report as received from a nurse refers to a female patient of unknown age. The patient pertinent medical history was not provided. The nurse reported that the patient received her first dose of GARDASIL (dose, route of administration, lot# and expiration date were unspecified) "two years and a couple months ago" and her second dose of GARDASIL (dose, route of administration, lot# and expiration date were unspecified) in approximately April 2014 (reported as "two months ago"). No adverse effect reported. Additional information has been requested.
Patient experienced redness and swelling around the injection site. She also complained of tingling and minor pains in her lower back down her left leg to her foot. No sign of a rash yet.
Patient reported feeling a sudden pressure or chest pain, after 15min from getting her vaccine, no other symptoms reported.  kept patient in the pharmacy area for an hour, watched her closely, checked her BP, and her BP was very high.  (197-107-77) then 180-100-78, then 25 minutes later 191-103-77, patient stated her usual BP is high and she is on BP meds(normally at 160/90, and that she had not taken her 2nd dose of prescribed valsartan today, and she is directed by doctor to take clonidine when her BP is high, so this is not abnormal for her, and she was advised to see her doctor asap.  Patient stated that she will call her doctor on his cell phone and will follow his direction.
4 hours after the injection felt sudden extreme body weakness and flushing, then collapsed. Near fainting, but never lost consciousness.  Recovered after sitting in a  chair for several minutes. Went home took my temp and blood pressure. Temp was 97.8,  BP 121/77. Pulse 59. Don't know if there are any other adverse events, too soon to tell. I had the Fluad trivalent flu shot last year, no major issues.but
Within minutes of getting the nasal spray H1N1 vaccine, my son reported a stomach ache. Within an hour and a half of getting the vaccine, he was vomiting. He contiuned to vomit over the next 5 hours. At the end of this time he had a couple of loose bowel movements.
Axillary lymphadenopathy on left side still ongoing over 7 weeks after vaccine. Planning mammogram and ultrasound in 2 days
Patient reported he started feeling funny.  Wasn't able to describe it, but that he felt funny.  His heart started racing at approx. 120 beats a minute.  It lasted about 2 minutes and then he felt ok.  He reported this to me (I was the one who gave him his shot) after the incident.
After finishing my second Shingrix vaccination shot in February 2023, I have since had shingles on June5 , again on July 19, and again on August 16. My dr prescribed Valacyclover HCI, 1 gram, 3 times a day for 7 days.  After finishing that Rx in June, I developed Shingles again about a month after finishing the Rx.  So with the July outbreak my Dr. told me to take ValACYclovir (same Rx) for two weeks, which I did.  Approximately one week after finishing that prescription, I had another outbreak in August.  Now he has me on the same Rx for 3 months!
SWOLLEN RED HOT ARM -- STARTED 8/15/2014 STILL REACTING AS OF 8/18/14 PT USING BENADRYL AND ICE PACKS TO REDUCE SWELLING AND STOP ITCHING.
The patient did not experience any symptoms; A patient was administered one dose of VARIVAX only 27 days after having recieved the MMR II vaccine; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. The patient's concurrent conditions, medical history, concomitant medications and drug reactions/allergies were not reported.  On 20-NOV-2019, the patient was vaccinated with one dose of varicella virus vaccine live (oka/merck) (VARIVAX) (lot # S012036 and expiration date: 17-APR-2021) subcutaneously for prophylaxis only 27 days after having received Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) (inappropriate schedule of product administration). The patient did not experience any symptoms (no adverse event). No product quality complaint (PQC) was involved.
PNEUMOVAX was injected rapidly into my right arm, and almost immediately my arm swelled from the elbow up (3x the normal size). In addition, it has affected my breathing, and led to chest pain, severe headaches, and swelling of my lips. It was also very painful. I was up all night and got no rest. The pharmacy was overloaded (1 pharmacist) and no after care/supportive care was offered by the pharmacist.
4 hours after the booster of SHINGRIX the patient experienced chills, a fever of 101 degrees for 24 hours.
This spontaneous report as received from a health professional refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 08-DEC-2015, the patient was vaccinated with improperly stored (exposed to the following temperatures and cumulative time frames colder than 36 F: In September 2015, the coldest temperature was 34 F for 346.7 hours (over 14 days); In October of 2015, the coldest temperature was 34 F for 492.6 hours for a total of 839.3 hours (35 days); In November of 2015, the coldest temperature was 34 F for 192 hours, for a total of 1,031.3 hours (43 days)) VAQTA injection, 0.5 ml (lot # L018499, exp. date: 25-FEB-2017) (route and strength unspecified). No concomitant medications were reported. No adverse effects have been reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of several reports received from the same reporter. Additional information has been requested.
I got ?Covid arm?. Red rash on the arm, hot swollen tender to the touch.